Number Needed to Treat Analysis for Planned Neck Dissection after Chemoradiotherapy for Advanced Neck Disease

被引:3
作者
Javidnia, Hedyeh [1 ]
Corsten, Martin J. [1 ]
机构
[1] Ottawa Hosp, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada
来源
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | 2010年 / 39卷 / 06期
关键词
chemoradiotherapy; neck dissection; neck metastasis; SQUAMOUS-CELL CARCINOMA; ADVANCED LARYNGEAL-CANCER; ADVANCED HEAD; CONCURRENT CHEMOTHERAPY; ORGAN-PRESERVATION; RADIATION-THERAPY; RANDOMIZED-TRIAL; POSITIVE NECK; HYPERFRACTIONATED RADIATION; INDUCTION CHEMOTHERAPY;
D O I
10.2310/7070.2010.090261
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To analyze how many planned neck dissections (PNDs) must be performed to prevent one fatal neck recurrence after chemoradiotherapy for head and neck cancer with regional metastasis. Methods: A systematic literature review of studies using chemoradiotherapy as primary treatment for head and neck cancer was performed. Data were extracted where possible to determine estimates for the following variables: (1) percentage of N2-3 necks still harbouring cancer after chemoradiotherapy as proven by pathology from neck dissection (C); (2) percentage of regional recurrence after PND (P); (3) percentage of regional recurrence after salvage neck dissection for patients without initial PND in whom neck disease recurred after chemoradiotherapy (S); and (4) mortality rate of PND (M). The number needed to treat was calculated using the following equation: NNT = 1/[C*(S+M) - (P+M)]. Results: The number needed to treat is 7.5. Conclusion: To prevent one fatal neck recurrence after chemoradiotherapy for head and neck cancer with N2-3 disease, one would need to perform 7.5 PNDs. The results of this study will aid surgeons and patients in making more informed decisions regarding neck dissections.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 36 条
[1]   Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution [J].
Adelstein, DJ ;
Saxton, JP ;
Rybicki, LA ;
Esclamado, RM ;
Wood, BG ;
Strome, M ;
Lavertu, P ;
Lorenz, RR ;
Carroll, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1064-1071
[2]   Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy [J].
Adelstein, DJ ;
Saxton, JP ;
Lavertu, P ;
Rybicki, LA ;
Esclamado, RM ;
Wood, BG ;
Strome, M ;
Carroll, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1405-1410
[3]   Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck - Pharmacokinetic and clinical data of a phase I-II study [J].
Airoldi, M ;
Cattel, L ;
Cortesina, G ;
Giordano, C ;
Pedani, F ;
Recalenda, V ;
Danova, M ;
Gabriele, AM ;
Tagini, V ;
Porta, C ;
Bumma, C .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (02) :155-163
[4]   Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].
Al-Sarraf, M ;
LeBlanc, M ;
Giri, PGS ;
Fu, KK ;
Cooper, J ;
Vuong, T ;
Forastiere, AA ;
Adams, G ;
Sakr, WA ;
Schuller, DE ;
Ensley, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317
[5]  
[Anonymous], 1991, NEW ENGL J MED
[6]   Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer [J].
Argiris, A ;
Stenson, KM ;
Brockstein, BE ;
Mittal, BB ;
Pelzer, H ;
Kies, MS ;
Jayaram, P ;
Portugal, L ;
Wenig, BL ;
Rosen, FR ;
Haraf, DJ ;
Vokes, EE .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (05) :447-455
[7]   Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [J].
Brizel, DM ;
Albers, ME ;
Fisher, SR ;
Scher, RL ;
Richtsmeier, WJ ;
Hars, V ;
George, SL ;
Huang, AT ;
Prosnitz, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1798-1804
[8]  
Calais G, 2000, B CANCER, V87, P48
[9]   Neck Dissection Following Concurrent Chemoradiation for Advanced Head and Neck Carcinoma: Pathologic Findings and Complications [J].
Christopoulos, Apostolos ;
Nguyen-Tan, Phuc Felix ;
Tabet, Jean-Claude ;
Fortin, Bernard ;
Soulieres, Denis ;
Charpentier, Danielle ;
Guertin, Louis .
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 37 (04) :452-456
[10]   The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease [J].
Clayman, GL ;
Johnson, CJ ;
Morrison, W ;
Ginsberg, L ;
Lippman, SM .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (02) :135-139